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Abstract 
Volatile substance abuse (VSA) is an under-recognised worldwide problem. Data, 
especially international comparisons, are limited. The 2005 ESPAD report 
published data on VSA from 35 countries, collected in 2003. Lifetime prevalence 
of VSA can be as high as 22 per cent, with little difference between boys and 
girls in most countries. Perceived risk of VSA is worryingly low (comparable to 
perceived risk of cannabis), varies greatly between countries, and does not seem 
to be related to levels of use within countries. Neither is perceived availability 
of volatile products related to national prevalence rates of misuse. 
 
International comparisons must be approached with caution, but this report 
gives useful data on an under-researched issue. 
Introduction 
Volatile Substance Abuse (VSA) is the misuse of substances such as gases, glues 
and aerosols (as well as, less commonly, a range of other substances) to achieve 
intoxication. While much VSA is experimental, it can be deadly, even at the 
‘experimental’ stage of misuse; VSA- related deaths in the UK (for which data has 
been collected since 1971) exceed 2,000 (Field-Smith et al 2002). In the UK, 
more teenage deaths are associated with VSA than with illegal drugs and, for 
some age groups, it is a bigger killer than causes of death such as leukaemia, 
pneumonia and drowning (ACMD 1995). 
 
It is a worldwide problem (e.g. Ives, 1996a), and can be particularly widespread 
among some indigenous groups (Ives, 1996b) and among some children living on 
the street (WHO, 1998). Chronic VSA is associated with poor socio-economic 
conditions and a range of social and psychological problems (Ives, 2000a; Ives, 
1999), and with delinquency and illegal drug use (NSDUH 2005). 
 
Despite the size of the problem, it has received much less attention than illegal 
drugs and alcohol. However, various ‘supply-side’ activities have been 
attempted, including product modification (MacLean and d’Abbs, forthcoming), a 
number of countries have controls on the sales of products containing ‘sniffable’ 
substances, and professionals have been issued with guidance on tackling the 
topic (e.g. see Ives 2000b).  
 
International survey evidence is also limited, especially time series data. Thus 
the publication of the Report on the 2003 ESPAD (European school Survey Project 
on Alcohol and other Drugs), which includes prevalence data on substance misuse 
including VSA, is a welcome addition to knowledge of the problem (Hibell, et al 
2005). ESPAD is a survey of 15- to16-year-old students in 35 European Countries. 
The organisers of the survey request a minimum of 2,400 students in each 
country.† Students answer a paper questionnaire administered at school. The 
2003 survey is the third of its kind; previous studies took place in 1995 and 1999. 
The study is co-ordinated by the Swedish Council for Information on Alcohol and 
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Other Drugs (CAN) and supported by the Council of Europe Pompidou Group and 
the Swedish National Institute of Public Health (see www.espad.org).  
 
This paper looks at the published data on VSA in this Report, and makes some 
observations on the information contained therein. While international 
comparisons should always be treated with caution (for example, because of 
possible differences in the ways that the survey was carried out in the different 
countries), this Report contains much of interest. 
Levels of VSA 
In the international report, the term used for VSA is ‘inhalants’, but the actual 
question about prevalence which was asked (in the appropriate languages of the 
countries surveyed, of course) was: ‘On how many occasions (if any) have you 
sniffed a substance (sniffing glue, aerosols, etc) to get high?’ It is known that 
reported prevalence of VSA is quite sensitive to questionnaire wording, and 
asking about it in different ways produces different results (Ives 1999). There will 
also be issues of translation and cultural adaptation of the wording. Country 
comparisons should be therefore treated as indicative rather than definitive. 
Lifetime prevalence 
The lifetime experience of VSA (i.e. whether they had ever tried VSA) among 
students in the 35 countries varied from two per cent (in Romania) to 22 per cent 
(in Greenland). The UK was (with Iceland) at 10th position, with 12 per cent of 
students reporting trying VSA. Countries with similar levels to the UK included 
France (11%) and Austria (14%). Table 1 gives a summary. 
 
Table 1 about here 
Sex differences 
There was generally little difference between boys’ and girls’ lifetime 
prevalence. Exceptions included Portugal (boys 10%; girls 6%), Belgium (boys 9%; 
girls 5%), Italy (boys 8%; girls 5%) and the Ukraine (boys 9%; girls 4%). In Ireland, 
the girls reported considerably higher misuse than boys (girls 21%; boys 14%).* 
The figures for the UK were boys: 12 per cent, and girls: 13 per cent. 
Changes over time 
There had been some changes in prevalence between the three surveys.† In the 
1995 survey (when fewer countries were included), UK students reported the 
highest levels of VSA (20%), while in the 1999 survey the UK rate, at 15 per cent, 
was exceeded by Ireland (22%), Greenland (19%), and Malta (16%).‡ Between 1999 
and 2003, the levels of lifetime prevalence had declined in Ireland (22% to 18%), 
Lithuania (10% to 5%) and the UK (15% to 12%) (as well as in Ukraine, Norway and 
Russia (Moscow)), but there had been increases in prevalence in (among other 
countries) Greenland (19% to 22%) and Portugal (3% to 8%).  
 
* The only other two countries where girls reported using more than boys were the Isle of Man and 
the Faroe Islands, but in these countries the differences between boys and girls were small.  
† Because of possible differences in sampling, etc, differences between the three surveys should 
not be over-interpreted.  
‡ Ireland and Greenland, among others, did not participate in the 1995 survey. 
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12-month and 30-day prevalence  
Since much VSA is experimental and many of those who try ‘sniffing’ only do so 
once or twice, lifetime prevalence can be high while current misuse may be low. 
As well as measuring lifetime prevalence, the researchers were also able to 
establish use in the 12 months prior to the survey and in the previous 30 days. 
VSA in the past 30 days will mean, in most cases, that the respondent is a current 
misuser. VSA in the past 12 months will, in most cases, indicate experimentation.  
 
The higher figures for use in the last 12 months and in the last 30 days are found 
in the same countries as those with higher lifetime prevalence. Table 2 shows the 
results for the 13 countries with the highest lifetime prevalence in 2003. While, 
as might be expected, Greenland had the highest 12-month prevalence (16%), 
Croatia and Cyprus had the highest 30-day prevalence (6%).  
 
Table 2 about here 
Perceived risk 
For each of the substances about which prevalence data were collected, students 
were also asked about the risk of using them. The response categories were: ‘no 
risk’; ‘slight risk’; ‘moderate risk’; ‘great risk’; and ‘don’t know’. The ESPAD 
report gives tables showing the percentage of students answering ‘great risk’ 
separately for use ‘once or twice’ and for use ‘regularly’. Table 3 has been 
compiled from these tables and shows data for selected countries (a table giving 
details for all 35 countries is available from the author on request). 
 
Table 3 about here 
 
On average, about a third (35%) of students thought that VSA ‘once or twice’ 
posed a great risk, while about two-thirds (68%) thought that use ‘regularly’ was 
a great risk. This compares with an average of 32 per cent who thought that that 
the risk of using cannabis once or twice was great, an average of 73 per cent who 
thought that regular ecstasy use would be a great risk, and 81 per cent who 
thought that regular injections of drugs would be a great risk. 
 
There were considerable variation between countries, with less than a fifth of 
German students (19%) seeing a great risk in use ‘once or twice’, compared to 
two-thirds (67%) of Cypriot students. Students in the Czech Republic reported the 
highest ‘great risk’ figure for use ‘regularly’ (85%), with the lowest being Malta 
(55%). 
 
There were some interesting differences between boys and girls on the two 
measures. In most countries, girls rated the danger of use ‘once or twice’ rather 
lower than boys did. This was true for 27 out of 35 countries, but often the 
difference was only a few percentage points, giving an average figure of 37 per 
cent for boys and 34 per cent for girls: a difference of only three per cent. In the 
UK, the figures were very close to the average for all countries, at 36 per cent 
for boys and 34 per cent for girls.  
 
But girls consistently rated the dangers of regular use higher than the boys did – 
on average, 72 per cent of girls rated regular use as a ‘great risk’ compared to 
only 65 per cent of boys. The only exception was the UK, where boys’ and girls’ 
ratings were equal, at 62 per cent.  
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As described earlier, there were few sex differences in the prevalence of VSA, 
but in most countries boys’ VSA was higher than girls, apart from Ireland where 
girls’ VSA exceeded boys’. Yet girls in Ireland were similar to other girls in other 
countries in rating the dangers of regular use higher than boys did (68% compared 
to 60%). 
Availability of volatile substances 
To gain an idea of how readily available drugs were, the researchers asked the 
students how easy it was to obtain various substances. The ESPAD report gives 
tables showing the percentage of students answering that volatile substances 
were ‘very easy’ or ‘fairly easy’ to obtain. Table 4 has been compiled from these 
tables and shows data for selected countries (a table giving details for all 35 
countries is available from the author on request).  
 
Table 4 about here 
 
Ireland, which had a high prevalence of VSA, had the highest rates of both boys 
(83%) and girls (71%) saying that volatile substances were very or fairly easy to 
obtain. The lowest figure was for Romania (13%), a country with lowest reported 
prevalence. About half (53%) of boys and girls in the UK - slightly more girls (55%) 
than boys (51%) - said that volatile substances were very or fairly easy to obtain. 
Discussion 
For those concerned about VSA, the ESPAD report contains some interesting 
indications, although it should be noted that cross-cultural comparisons are 
fraught with difficulty, and the published data are in summary form only and do 
not permit detailed analysis. A caveat has already been entered about the 
sensitivity of reported VSA prevalence to question wording. It should also be 
noted that ESPAD is a school-based survey and therefore does not include young 
people who are not in school at the time of the survey. Since school refusers are 
disproportionately likely to misuse substances the ESPAD figures will probably be 
underestimates. There may be differences between countries in the degree of 
under-reporting – for example, a high prevalence of VSA has been reported 
among Romanian street-children but they are unlikely to be in school and 
therefore to be included in the survey. 
 
It will be of particular interest to UK readers that there are now nine countries 
with a higher prevalence than the UK. This is partly because of a decline in 
reported prevalence in the UK between 1995 and 1999 and (to a lesser extent) 
between 1999 and 2003.* No country other than the UK specifically monitors VSA–
related deaths (Field-Smith et al 2005), but there is no reason to believe that 
there are not similar numbers of deaths associated with VSA in countries with 
similar prevalence levels. VSA is a world-wide problem and deserves more 
attention, especially from those countries with high levels of prevalence. 
 
It is interesting to note that students in Ireland, a country with high prevalence 
levels, were most likely to say that obtaining volatile substances was very or 
fairly easy, whereas students in Romania – the country with the lowest 
 
* Four countries with higher prevalence levels than the UK in 2003 – Ireland, Greenland, Slovenia 
and Greece - did not participate in the 1995 survey (nor did Romania, Bulgaria, Russia, Latvia and 
France); Cyprus, while participating in 1995, did not take part in 1999. 
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prevalence – were least likely to say this. However, it is important not to jump to 
the conclusion that easy access leads to increased use. It could be, for example, 
that the Romanian students didn’t know what substances could be misused and 
so thought that they must be difficult to obtain; or because Romania is a poor 
country, perhaps the students were referring to the lack of money to buy volatile 
substances. Nevertheless, these associations are worth further investigation.  
 
The ESPAD report comments that students in Greenland had not heard of many of 
the drugs which were asked about – and if other drugs are not available this 
might be an explanation for the higher levels of VSA prevalence in Greenland. If 
this is the case, then it is an interesting example of the idea that some people 
will satisfy their desire for intoxication with whatever substance is available. 
However, as noted previously, 30-day prevalence rates for VSA in Greenland were 
not the highest, implying, perhaps, that much VSA in Greenland is experimental 
and short-term only. 
 
It is worrying that only about a third of students considered that trying VSA once 
or twice was a great risk – a figure very close to that for cannabis. While the 
message about the dangers of injecting drugs seems to have reached large 
proportions of young people in most countries, the message about the particular 
risks of experimental VSA has not got through. In fact, it is likely that in most 
countries the message has not even been conveyed. Since the UK has around 
average figures on this measure, it seems that the limited amount of publicity 
about the dangers of VSA has not had much effect. It is probably not reassuring 
that assessment of risk seems to bear little relationship to use – the most obvious 
example being that girls in Ireland are not only more likely than boys to try 
volatile substances but also to rate their regular use as a great risk. 
 
This paper has included all the VSA-related data given in ESPAD report. 
Unfortunately, VSA has not been consistently included in the ESPAD questions or 
analysis. For example, the researchers asked about the first illicit drug that the 
students had ever used, but did not include volatile substances in their list – 
surprising, because for many this will be (along with alcohol) the first drug tried.*
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Table 1 Lifetime prevalence of VSA in ESPAD 2003 Survey 
 5% or less 6% to 10%  11% to 15% 16% or more 
Countries 
(percentages in 
brackets) 
 
6 countries:  
5% or less 
15 countries: 
between 6 and 
10% 
9 countries: 
between 11 
and 15% 
5 countries: 
16% or more  
Romania (2) 
Bulgaria (3) 
Turkey (4) * 
Norway (5) 
Lithuania (5) 
Hungary (5) 
Ukraine(6) 
Netherlands(6) 
Italy (6) 
Switzerland (7) 
Russia (7) * 
Latvia (7) 
Belgium (7) 
Sweden (8) 
Portugal (8) 
Finland (8) 
Estonia (8) 
Denmark (8) 
Slovak Republic 
(9) 
Poland (9) 
Czech Rep (9) 
Germany (11) 
France (11) 
Faroe Is. (11) 
UK (12) 
Iceland (12) 
Croatia (14) 
Austria (14) 
Slovenia (15) 
Greece (15) 
 
Malta (16) 
Ireland (18) 
Cyprus (18) 
Isle of Man (19) 
Greenland (22) 
* Turkish survey covered six cities. Russian survey covered Moscow only. 
Based on Figures 56a and 56b (page 173) and Table 36c (page 401) in ESPAD 2003 survey report  
 
Table 2 VSA prevalence levels for 13 countries: Lifetime, 12 months, and 30-days 
Country Lifetime 
prevalence 
12 month 
prevalence 
30 day 
prevalence 
France  
Faroe Is.  
UK  
Iceland  
Croatia  
Austria 
Slovenia  
Greece  
Malta  
Ireland 
Cyprus  
Isle of Man 
Greenland  
11 
11 
12 
12 
14 
14 
15 
15 
16 
18 
18 
19 
22 
5 
7 
7 
8 
11 
6 
7 
8 
10 
10 
11 
11 
16 
2 
2 
3 
3 
6 
3 
4 
5 
5 
3 
6 
4 
4 
Based on Figures 56a and 56b (page 173) and Table 36c (page 401) in the ESPAD 2003 survey  
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Table 3 Perceived risk of volatile substance abuse (selected countries) 
(Percentage answering ‘Great risk’) 
Country ‘Once or twice’ ‘Regularly’ 
 boys girls total boys girls total 
Austria 24 17 21 57 65 61 
Bulgaria 39 36 37 64 73 69 
Croatia 40 35 37 61 68 65 
Cyprus 64 74 67 69 75 72 
Czech Rep. 43 33 38 82 87 85 
France  44 38 41 73 78 76 
Germany 21 18 19 56 64 60 
Greece  36 30 33 66 69 68 
Hungary 31 29 30 67 74 70 
Iceland 54 55 55 77 87 82 
Ireland 36 34 35 60 68 64 
Italy 43 40 41 63 66 65 
Lithuania 58 53 55 74 83 78 
Malta 27 21 24 53 57 55 
Netherlands 23 19 21 55 62 59 
Norway  31 26 29 70 79 74 
Romania 42 45 44 58 68 64 
Slovenia 28 20 24 57 61 59 
Sweden 27 24 25 66 72 69 
UK 36 34 35 62 62 62 
AVERAGE* 37 34 35 65 72 68 
Based on Tables 43a, b & c ESPAD Appendix II page 418-20 in the ESPAD 2003 survey 
* of all 35 countries (excluding Greenland) 
 
Table 4 Availability of volatile substances (selected countries) 
Country ‘Very easy’ or ‘fairly easy’ to obtain: 
percentages  
 boys girls total 
Austria 52 60 56 
Bulgaria 30 34 32 
Croatia 47 53 50 
Cyprus 53 51 52 
Czech Rep 54 42 47 
France  36 36 36 
Germany 60 61 60 
Greece  47 45 46 
Hungary 37 38 37 
Iceland 45 44 45 
Ireland 83 71 77 
Italy 17 15 16 
Lithuania 28 29 28 
Malta 36 42 29 
Netherlands 38 33 36 
Norway  38 35 37 
Romania 15 12 13 
Slovenia 57 65 61 
Sweden 51 51 51 
UK 51 55 53 
AVERAGE* 42 40 41 
Based on Figures 58a and 58b (page 179) and Tables 42a, b & c ESPAD Appendix II page 415-17 in 
the ESPAD 2003 survey 
* of all 35 countries 
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